Conversion from Cyclosporine to Tacrolimus Improves Quality-of-Life Indices, Renal Graft Function and Cardiovascular Risk Profile-Reference-Cited by-同舟云学术

Conversion from Cyclosporine to Tacrolimus Improves Quality-of-Life Indices, Renal Graft Function and Cardiovascular Risk Profile

Published:2004-06 Issue:6 Volume:4 Page:937-945
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Artz Marika A.,Boots Johannes M. M.,Ligtenberg Gerry,Roodnat Joke I.,Christiaans Maarten H. L.,Vos Pieter F.,Moons Philip,Borm George,Hilbrands Luuk B.

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-6143.2004.00427.x/fullpdf

Reference37 articles.

1. Cardiovascular Risk Factors in Renal Transplant Patients: Cyclosporin AVersusTacrolimus

2. Early graft function and patient survival following cadaveric renal transplantation

3. Hyperlipidaemia in renal transplantation—risk factor for long-term graft outcome

4. A COMPARISON OF TACROLIMUS (FK506) AND CYCLOSPORINE FOR IMMUNOSUPPRESSION AFTER CADAVERIC RENAL TRANSPLANTATION1

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of tacrolimus on proteinuria in Chinese and Indian patients with idiopathic membranous nephropathy: the results of machine learning study;International Urology and Nephrology;2024-04-20

2. Case report: Successful treatment of acute generalized pustular psoriasis with multiple comorbidities with oral tacrolimus;Frontiers in Immunology;2024-03-19

3. Systemic calcineurin inhibitors tacrolimus and voclosporin: A review of off-label dermatologic uses;Journal of the American Academy of Dermatology;2024-02

4. Minimizing Metabolic and Cardiac Risk Factors to Maximize Outcomes After Liver Transplantation;Transplantation;2023-12-07

5. Advances in alginate encapsulation of pancreatic islets for immunoprotection in type 1 diabetes;Journal of Pharmaceutical Investigation;2023-06-29